Since the discovery of the role of BRCA1 and BRCA2 in hereditary BC, successful germline analysis of BRCA1, BRCA2, and other BC susceptibility genes has provided the foundation for genetics’ utility in screening, cancer risk reduction, and treatment [12]. This evidence concerns the gene BRCA2 and breast cancer.